GLAXOSMITHKLINE PLC ORD 25P – Consensus Indicates Potential 28.7% Upside

Broker Ratings

GLAXOSMITHKLINE PLC ORD 25P with EPIC code (LON:GSK) now have 20 analysts covering the company. The range between the high target price and low target price is between £19.00 and £14. so the average target price would be £16.45. With the shares previous close at £12.78 this would imply there is a potential upside of 28.7%. The 50 day moving average now sits at £13.56 and the 200 moving average now moves to £14.22. The market cap for the company is £64b. Company Website: http://www.gsk.com

GlaxoSmithKline plc engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, and dermatology. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories. The company offers its consumer healthcare products in the form of nasal sprays, tablets, syrups, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, liquid filled suspension, wipes, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, lip balm, gummies, and soft chews. It has collaboration agreements with 23andMe; Merck KGaA; Lyell Immunopharma; Novartis; CEPI; Innovax and Xiamen University; VBI; Viome; Sanofi SA; and CureVac. GlaxoSmithKline plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.

Good news travels fast (but only if you make that happen):

Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on facebook
Facebook
Share on email
Email
Share on whatsapp
WhatsApp